Article 19 Nov 2025 New FDA Guidance Aims To Simplify The Biosimilar Approval Process United States Healthcare
Article 03 Oct 2025 Life Sciences And Medtech Policy Update: Key Things To Know Q4 2025 United States Healthcare
Article 07 Aug 2025 Move Fast: FDA Is Accepting Submissions For The Pilot Program Class For FDA Commissioner's National Priority Voucher Program United States Healthcare
Article 16 Jul 2025 FDA's Push For "Radical Transparency": Key Takeaways From The Agency's Publication Of Complete Response Letters United States Healthcare
Article 19 May 2025 President Trump Issues Two Executive Orders Concerning The Affordability And Accessibility Of Drugs United States Healthcare
Article 14 May 2025 Most Favored Nation Drug Pricing Executive Order Resurrects Prior President Trump Policy United States Healthcare
Article 28 Apr 2025 Charting A Conditional Approval Pathway For Rare Disease Drugs – A Top Priority For A Revamped FDA? United States Healthcare
Article 22 Jan 2025 How To (Finally) Get Your SIUU Out: FDA Issues Final Guidance On Communicating Off-Label Scientific Information United States Healthcare
Article 03 Oct 2024 A Look Ahead In Life Sciences: What We Are Tracking In The Fourth Quarter Of 2024 And Beyond United Kingdom Healthcare
Article 01 Jul 2024 FDA Issues Overdue Draft Guidance On Clinical Trial Diversity Action Plans United States Healthcare
Article 16 Jan 2024 Goodwin Releases Update To Its Comprehensive Guide To Biosimilars Litigation And Regulation In The U.S. United States IP
Article 09 Jan 2024 A Look Ahead In Life Sciences: What We Are Tracking In Q1 2024 And Beyond Worldwide Healthcare
Article 27 Oct 2023 How To Get Your SIUU Out: FDA Provides Long-Awaited Update For Industry On Communicating Off-Label Information United States Healthcare
Article 02 Jan 2023 Congress Expands Pathway For Drug & Device Manufacturers' Pre-Approval Communication Of Health Care Economic Information To Payors, Formularies, & Similar Entities United States Healthcare
Article 02 May 2022 Clinical Trial Diversity Planning For Sponsors: What To Know About FDA's Recent Draft Guidance United States Healthcare